Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Antithrombin-III activator DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Venous Thrombosis 4 D020246 ClinicalTrials
Thrombosis 4 D013927 ClinicalTrials
Pulmonary Embolism 4 D011655 ClinicalTrials
Myocardial Infarction 4 D009203 ClinicalTrials
Genital Neoplasms, Female 3 D005833 ClinicalTrials
Obesity 3 D009765 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Liver Cirrhosis 3 D008103 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Infections 3 D007239 ClinicalTrials
Small Cell Lung Carcinoma 3 D055752 ClinicalTrials
Kidney Diseases 3 D007674 ClinicalTrials
Hip Fractures 3 D006620 ClinicalTrials
ST Elevation Myocardial Infarction 3 D000072657 ClinicalTrials
Myocardial Ischemia 3 D017202 ClinicalTrials
Thromboembolism 3 D013923 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Venous Thromboembolism 3 D054556 ClinicalTrials
Fetal Growth Retardation 3 D005317 ClinicalTrials
Abortion, Habitual 3 D000026 ClinicalTrials
Atrial Fibrillation 3 D001281 ClinicalTrials
Stroke 2 D020521 ClinicalTrials
Staphylococcal Infections 2 D013203 ClinicalTrials
Blood Coagulation Disorders 2 D001778 ClinicalTrials
Nephrotic Syndrome 2 D009404 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Hemorrhage 1 D006470 ClinicalTrials
Acute Coronary Syndrome 1 D054058 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
15.37
General disorders and administration site conditions
13.81
Injury, poisoning and procedural complications
13.31
Skin and subcutaneous tissue disorders
7.63
Nervous system disorders
6.41
Gastrointestinal disorders
5.79
Pregnancy, puerperium and perinatal conditions
4.55
Respiratory, thoracic and mediastinal disorders
4.52
Cardiac disorders
4.0
Investigations
3.6
Musculoskeletal and connective tissue disorders
3.42
Blood and lymphatic system disorders
3.11

Cross References

Resources Reference
ChEMBL CHEMBL1201476
FDA SRS 8NZ41MIK1O
PubChem 772